Israeli generics giant Teva Pharmaceutical Industries (TLV: TEVA) has reported its latest quarterly financial results against a backdrop of war in its home regi 8 November 2023
London-headquartered generics company Hikma Pharmaceuticals has announced that its chief executive Siggi Olafsson has resigned in order to ‘pursue other opportu 26 May 2022
UK-based medicines manufacturer and supplier Morningside Pharmaceuticals has appointed a new chief executive, with previous CEO Nik Kotecha to take on a strateg 7 October 2020
Israel’s largest drugmaker and generics giant Teva Pharmaceutical beat analysts’ profit forecasts for the second quarter, with a slightly smaller dip in profits 5 August 2020
Shares in Teva Pharmaceutical Industries were up by 10% after 90 minutes of New York trading on Thursday, following the company’s presentation of its third-quar 7 November 2019
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.